Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement commission backs off from consumer summaries in notification letters.

This article was originally published in The Tan Sheet

Executive Summary

SUPPLEMENT COMMISSION BACKS OFF FROM PROPOSED CONSUMER SUMMARIES accompanying notification letters for structure/function claims submitted to FDA, the group decided at an Aug. 14-15 meeting in Reston, Va. The commission's June 24 draft report on supplement labeling called for supplement manufacturers to make consumer summaries of claims substantiation and safety information publicly available for each product sold bearing a structure/function claim ("The Tan Sheet" June 30, p. 19). The Dietary Supplement Health & Education Act requires companies to submit a notification letter to FDA within 30 days of marketing a dietary supplement indicating the structure/function claims being made for the product.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel